Stryker (NYSE:SYK) Misses Q1 CY2026 Sales ExpectationsMedical technology company Stryker (
NYSE:SYK) missed Wall Street’s revenue expectations in Q1 CY2026 as sales rose 2.6% year on year to $6.02 billion. Its no...
Stryker reports first quarter 2026 operating resultsPortage, Michigan, April 30, 2026 (GLOBE NEWSWIRE) -- Stryker (
NYSE:SYK) reported operating results for the first quarter of 2026:
Stryker (SYK) Q1 Earnings: What To ExpectMedical technology company Stryker (
NYSE:SYK) will be reporting earnings this Thursday after the bell. Here’s what to look for. Stryker beat analysts’ revenu...
2 Large-Cap Stocks Worth Investigating and 1 We Turn DownLarge-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are...
Berger Montague PC Investigates Stryker Corporation’s Board of Directors for Breach of Fiduciary Duty (NYSE: SYK)PHILADELPHIA, April 24, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC advises shareholders of Stryker Corporation (
NYSE: SYK) (“Stryker” or the “Company”) about an investigation into Stryker’s Board of Directors (the “Board”) for potential breaches of fiduciary duties owed to the Company and its shareholders. The investigation focuses on whether the Board failed to exercise appropriate oversight regarding its cybersecurity and data protection practices, including the Company’s response to a recent cyber incident affecting its operations and data environment.
2 Profitable Stocks to Target This Week and 1 Facing HeadwindsEven if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
Boston Scientific’s $14.9 Billion Bet: The Strategic "Homecoming" to Neurovascular DominanceAs of April 15, 2026, the medical technology landscape is bracing for its most significant transformation in years. Boston Scientific (
NYSE:BSX) is moving steadily toward the finalization of its $14.9 billion acquisition of Penumbra, Inc. (
NYSE:PEN), a deal that represents the company's largest M&A move in
Consolidation Fever: Boston Scientific’s $14.9 Billion Bet on Penumbra Signals New Era in MedTech M&AIn a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (
NYSE: BSX) announced its definitive agreement to acquire Penumbra, Inc. (
NYSE: PEN) for approximately $14.9 billion. The deal, priced at $374.00 per share, represents a significant premium for Penumbra shareholders and marks one of
Organogenesis Clears Major FDA Hurdle: Path to First Non-Surgical Biologic for Knee Osteoarthritis WidensCANTON, Mass. — In a milestone development for the regenerative medicine sector, Organogenesis Holdings Inc. (Nasdaq: ORGO) announced today that it has successfully concluded a pivotal Type B meeting with the U.S. Food and Drug Administration (FDA), cementing its plans to finalize the Biologics License Application (BLA) for ReNu, its
Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolioPortage, Michigan, April 13, 2026 (GLOBE NEWSWIRE) -- Stryker (
NYSE:SYK), a global leader in medical technologies, announced that it has signed a definitive agreement to acquire Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology company developing a next-generation intravascular lithotripsy (IVL) platform designed to treat calcified peripheral arterial disease.
1 Healthcare Stock with Promising Prospects and 2 Facing HeadwindsHealthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali...
Stryker (SYK): Buy, Sell, or Hold Post Q4 Earnings?Over the last six months, Stryker shares have sunk to $342.00, producing a disappointing 7.6% loss - worse than the S&P 500’s 1.8% drop. This may have invest...
The Evolution of a MedTech Giant: A Deep Dive into Becton, Dickinson and Company (BDX)As of April 1, 2026, Becton, Dickinson and Company (
NYSE: BDX), commonly known as BD, finds itself at a historic crossroads. For decades, BD was viewed as a diversified healthcare conglomerate—a "steady Eddie" of the MedTech world that provided everything from basic syringes to complex diagnostic laboratory equipment. However, the recent completion of the Biosciences [...]
Stryker to announce financial results for its first quarter of fiscal year 2026Portage, Michigan, April 01, 2026 (GLOBE NEWSWIRE) -- Stryker (
NYSE:SYK) announced that it will report financial results for its first quarter of fiscal year 2026 on Thursday, April 30, 2026. A press release will be issued at approximately 4:05 p.m. ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company’s first quarter that ended March 31, 2026.
Stryker names Nick Mead Vice President, Investor RelationsJason Beach appointed Vice President, Group CFO, MedSurg and Neurotechnology
2 Large-Cap Stocks with Exciting Potential and 1 Facing HeadwindsLarge-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are...
Stryker announces Annual Meeting of ShareholdersPortage, Michigan, March 23, 2026 (GLOBE NEWSWIRE) -- Stryker (
NYSE:SYK) announced its 2026 Annual Meeting of Shareholders is scheduled as follows:
1 Oversold Stock Primed to Rebound and 2 We QuestionRock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investo...
Stocks making big moves yesterday: El Pollo Loco, Stryker, Dollar Tree, Coinbase, and Distribution SolutionsCheck out the companies making headlines yesterday: El Pollo Loco (
NASDAQ:LOCO): Fast food chain El Pollo Loco (
NASDAQ:LOCO) rose by 5.4% on Monday after the...
Stryker (SYK) Stock Is Up, What You Need To KnowWhat Happened? Shares of medical technology company Stryker (
NYSE:SYK) jumped 3.2% in the afternoon session after investors appeared to buy the dip after the...
